ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0171

The Association Between Short-Term Trajectory Of Atmospheric Particulate Matter 10 (PM10) Concentration And Hyperuricemia

Sunggun Lee1, Minyoung Her1, Seong-HO Kim1, Yong-Gil Kim2 and Ji Seon Oh2, 1Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea, 2Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, Seoul, Republic of Korea

Meeting: ACR Convergence 2025

Keywords: Environmental factors, gout, hyperuricemia

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0145–0174) Epidemiology & Public Health Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: The association between high atmospheric particulate matter concentration and gout flare has been reported1, but the causality and mechanism of this association remain unknown. We studied the association between trajectories of particulate matter concentration and hyperuricemia.

Methods: The seventh Korean National Health and Nutrition Examination Survey (2016–2018) linked air pollution concentration data was used. Trajectories of atmospheric particulate matter ≤10 ㎛ (PM10) concentrations from the day of serum uric acid measurement to 14 days prior (a total of 15 days) were clustered based on measures selected from principal component analysis. Hyperuricemia was defined as ≥7.0 mg/dL for men and ≥6.0 mg/dL for women. The association between the prevalence of hyperuricemia and quartiles of mean PM10 concentration or trajectories of PM10 concentration in the previous 15 days was modeled using generalized additive models, including age, sex, household income, obesity, chronic kidney disease, alcohol intake, mean temperature (spline), and mean relative humidity (spline). The associations were tested using weighted logistic regression models.

Results: The prevalence of hyperuricemia was 20.5% (95% confidence interval [CI], 19.2%–21.9%) in men and 6.1% (95% CI 5.5%–6.8%) in women. Mean PM10 concentration in the 15 days was 48.6 ng/mL (95% CI 47.4–49.9). There were three short-term trajectories of atmospheric PM10 concentrations: decreasing (N&#3f4289, 32%), increasing (N&#3f4724, 34%), and rapidly increasing (N&#3f4688, 34%) (figure 1). There was no significant association between hyperuricemia and quartiles of mean PM10 concentration in prior 15 days; Q1: reference, Q2: odds ratio [OR] 0.81 (95% CI 0.69–0.96), Q3: OR 0.89 (95% CI 0.74–1.07), and Q4: OR 0.86 (95% CI 0.71–1.04). However, the short-term trajectory of PM10 levels was significantly associated with hyperuricemia. Compared with the decreasing trajectory, the increasing (OR 0.88 [95% CI 0.76–1.00], P = 0.056) and rapidly increasing (OR 0.85 [95% CI 0.74–0.97], P = 0.018) trajectories were negatively associated with hyperuricemia. When the association was analyzed using weighted generalized linear models, there was a similar trend for negative association between hyperuricemia and the rapidly increasing trajectory; decreasing trajectory: reference, increasing trajectory: OR 0.93 (95% CI 0.79–1.09, P-value 0.251), rapidly increasing trajectory: OR 0.89 (95% CI 0.75–1.07, P-value 0.081). In the receiver operating characteristic curve analysis, model discrimination was significantly better using the GAM model (Model 1 in figure 2, P < 0.001).

Conclusion: Compared with decreasing trajectory, rapidly increasing trajectory of atmospheric PM10 concentration was associated with lower prevalence of hyperuricemia. The results suggest that the mobilization of urate crystals may be the cause of gout flares associated with air pollution. This hypothesis must be validated through longitudinal studies.Reference 1. Ryu HJ, Seo MR, Choi HJ, Cho J, Baek HJ. Particulate matter (PM(10)) as a newly identified environmental risk factor for acute gout flares: A time-series study. Joint Bone Spine. 2021;88(2):105108.

Supporting image 1Figure 1. Pointwise mean trajectories and 95% confidence intervals of particulate matter 10 concentration from the day of serum uric acid measurement to 14 days prior (The day when blood samples were obtained is 1 on the X-axis)

Supporting image 2Figure 2. The receiver operating characteristic curve analysis of model discrimination by the generalized additive model (Model 1) and the logistic regression model (Model 2)


Disclosures: S. Lee: None; M. Her: None; S. Kim: None; Y. Kim: None; J. Oh: None.

To cite this abstract in AMA style:

Lee S, Her M, Kim S, Kim Y, Oh J. The Association Between Short-Term Trajectory Of Atmospheric Particulate Matter 10 (PM10) Concentration And Hyperuricemia [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/the-association-between-short-term-trajectory-of-atmospheric-particulate-matter-10-pm10-concentration-and-hyperuricemia/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-association-between-short-term-trajectory-of-atmospheric-particulate-matter-10-pm10-concentration-and-hyperuricemia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology